{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:36:07Z","timestamp":1790386567341,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Intra-arterial cell infusion is an efficient delivery route with which to target organs such as the ischemic brain. However, adverse events including microembolisms and decreased cerebral blood flow were recently reported after intra-arterial cell delivery in rodent models, raising safety concerns. We tested the hypothesis that cell dose, infusion volume, and velocity would be related to the severity of complications after intra-arterial cell delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, 38 rats were subjected to a sham middle cerebral artery occlusion (sham-MCAO) procedure before being infused with allogeneic bone-marrow mesenchymal stem cells at different cell doses (0 to 1.0\u2009\u00d7\u200910\n                      <jats:sup>6<\/jats:sup>\n                      ), infusion volumes (0.5 to 1.0\u00a0ml), and infusion times (3 to 6\u00a0minutes). An additional group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094) was infused with 1.0\u2009\u00d7\u200910\n                      <jats:sup>6<\/jats:sup>\n                      cells labeled with iron oxide for\n                      <jats:italic>in vivo<\/jats:italic>\n                      tracking of cells. Cells were infused through the external carotid artery under laser Doppler flowmetry monitoring 48\u00a0hours after sham-MCAO. Magnetic resonance imaging (MRI) was performed 24\u00a0hours after cell infusion to reveal cerebral embolisms or hemorrhage. Limb placing, cylinder, and open field tests were conducted to assess sensorimotor functions before the rats were perfused for histology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A cell dose-related reduction in cerebral blood flow was noted, as well as an increase in embolic events and concomitant lesion size, and sensorimotor impairment. In addition, a low infusion velocity (0.5\u00a0ml\/6\u00a0minutes) was associated with high rate of complications. Lesions on MRI were confirmed with histology and corresponded to necrotic cell loss and blood-brain barrier leakage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Particularly cell dose but also infusion velocity contribute to complications encountered after intra-arterial cell transplantation. This should be considered before planning efficacy studies in rats and, potentially, in patients with stroke.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/scrt544","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:22:37Z","timestamp":1434586957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity"],"prefix":"10.1186","volume":"6","author":[{"given":"Li-li","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erja","family":"Kerkel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhameed","family":"Bakreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Nitzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Andrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Boltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lukomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Jolkkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","volume":"40","author":"GJ Del Zoppo","year":"2009","unstructured":"Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association\/American Stroke Association.\n                           Stroke 2009, 40:2945\u20138. 10.1161\/STROKEAHA.109.192535","journal-title":"Stroke"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.STR.0000247888.25985.62","volume":"38","author":"T Bliss","year":"2007","unstructured":"Bliss T, Guzman R, Daadi M, Steinberg GK: Cell transplantation therapy for stroke.\n                           Stroke. 2007, 38:817\u201326. 10.1161\/01.STR.0000247888.25985.62","journal-title":"Stroke"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, Mclntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al.: Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.\n                           PLoS One. 2012, 7:e47559. 10.1371\/journal.pone.0047559","journal-title":"PLoS One"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/jcbfm.2013.91","volume":"33","author":"MA Eckert","year":"2013","unstructured":"Eckert MA, Vu Q, Xie K, Yu J, Liao W, Cramer SC, et al.: Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.\n                           J Cereb Blood Flow Metab. 2013, 33:1322\u201334. 10.1038\/jcbfm.2013.91","journal-title":"J Cereb Blood Flow Metab"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","volume":"115","author":"A Bhasin","year":"2013","unstructured":"Bhasin A, Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S: Stem cell therapy: a clinical trial of stroke.\n                           Clin Neurol Neurosurg. 2013, 115:1003\u20138. 10.1016\/j.clineuro.2012.10.015","journal-title":"Clin Neurol Neurosurg"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al.: A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.\n                           Stem Cells. 2010, 28:1099\u2013106. 10.1002\/stem.430","journal-title":"Stem Cells"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","volume":"134","author":"O Honmou","year":"2011","unstructured":"Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al.: Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.\n                           Brain. 2011, 134:1790\u2013807. 10.1093\/brain\/awr063","journal-title":"Brain"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"e60049","DOI":"10.1371\/journal.pone.0060049","volume":"8","author":"GV Goldmacher","year":"2013","unstructured":"Goldmacher GV, Nasser R, Lee DY, Yigit S, Rosenwasser R, Iacovitti L: Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model.\n                           PLoS One. 2013, 8:e60049. 10.1371\/journal.pone.0060049","journal-title":"PLoS One"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/rme.13.2","volume":"8","author":"PH Rosado-de-Castro","year":"2013","unstructured":"Rosado-de-Castro PH, Schmidt Fda R, Battistella V, de Souza SAL, Gutfilen B, Goldenberg RC, et al.: Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients.\n                           Regen Med. 2013, 8:145\u201355. 10.2217\/rme.13.2","journal-title":"Regen Med"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3727\/096368911X576036","volume":"21","author":"J Lundberg","year":"2012","unstructured":"Lundberg J, Sodersten E, Sundstrom E, Le Blanc K, Andersson T, Hermanson O, et al.: Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression.\n                           Cell Transplant. 2012, 21:333\u201343. 10.3727\/096368911X576036","journal-title":"Cell Transplant"},{"key":"425_CR11","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1212\/WNL.0b013e31826959d2","volume":"79","author":"V Misra","year":"2012","unstructured":"Misra V, Ritchie MM, Stone LL, Low WC, Janardhan V: Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy.\n                           Neurology. 2012, 79:S207\u201312. 10.1212\/WNL.0b013e31826959d2","journal-title":"Neurology"},{"key":"425_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/jcbfm.2009.238","volume":"30","author":"L Li","year":"2010","unstructured":"Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q, et al.: Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study.\n                           J Cereb Blood Flow Metab. 2010, 30:653\u201362. 10.1038\/jcbfm.2009.238","journal-title":"J Cereb Blood Flow Metab"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","volume":"39","author":"P Walczak","year":"2008","unstructured":"Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al.: Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.\n                           Stroke. 2008, 39:1569\u201374. 10.1161\/STROKEAHA.107.502047","journal-title":"Stroke"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/jcbfm.2010.213","volume":"31","author":"JY Chua","year":"2011","unstructured":"Chua JY, Pendharkar AV, Wang N, Choi R, Andres RH, Gaeta X, et al.: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes.\n                           J Cereb Blood Flow Metab. 2011, 31:1263\u201371. 10.1038\/jcbfm.2010.213","journal-title":"J Cereb Blood Flow Metab"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/jcbfm.2013.32","volume":"33","author":"M Janowski","year":"2013","unstructured":"Janowski M, Lyczek A, Engels C, Xu J, Lukomska B, Bulte JW, et al.: Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation.\n                           J Cereb Blood Flow Metab. 2013, 33:921\u20137. 10.1038\/jcbfm.2013.32","journal-title":"J Cereb Blood Flow Metab"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-2999(00)00409-X","volume":"400","author":"J Jolkkonen","year":"2000","unstructured":"Jolkkonen J, Puurunen K, Rantakomi S, Harkonen A, Haapalinna A, Sivenius J: Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats.\n                           Eur J Pharmacol. 2000, 400:211\u20139. 10.1016\/S0014-2999(00)00409-X","journal-title":"Eur J Pharmacol"},{"key":"425_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0028-3908(00)00182-9","volume":"40","author":"K Puurunen","year":"2001","unstructured":"Puurunen K, Jolkkonen J, Sirvio J, Haapalinna A, Sivenius J: An alpha (2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats.\n                           Neuropharmacology. 2001, 40:597\u2013606. 10.1016\/S0028-3908(00)00182-9","journal-title":"Neuropharmacology"},{"key":"425_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0091-3057(02)01053-5","volume":"74","author":"H Karhunen","year":"2003","unstructured":"Karhunen H, Virtanen T, Schallert T, Sivenius J, Jolkkonen J: Forelimb use after focal cerebral ischemia in rats treated with an alpha 2-adrenoceptor antagonist.\n                           Pharmacol Biochem Behav. 2003, 74:663\u20139. 10.1016\/S0091-3057(02)01053-5","journal-title":"Pharmacol Biochem Behav"},{"key":"425_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0006-8993(02)03829-5","volume":"961","author":"MW Roos","year":"2003","unstructured":"Roos MW, Ericsson A, Berg M, Sperber GO, Sjoquist M, Meyerson BJ: Functional evaluation of cerebral microembolization in the rat.\n                           Brain Res. 2003, 961:15\u201321. 10.1016\/S0006-8993(02)03829-5","journal-title":"Brain Res"},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10520298009067258","volume":"55","author":"F Gallyas","year":"1980","unstructured":"Gallyas F, Wolff JR, Bottcher H, Zaborszky L: A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system.\n                           Stain Technol. 1980, 55:299\u2013306.","journal-title":"Stain Technol"},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/jcbfm.2010.202","volume":"31","author":"NM Hayward","year":"2011","unstructured":"Hayward NM, Yanev P, Haapasalo A, Miettinen R, Hiltunen M, Grohn O, et al.: Chronic hyperperfusion and angiogenesis follow subacute hypoperfusion in the thalamus of rats with focal cerebral ischemia.\n                           J Cereb Blood Flow Metab. 2011, 31:1119\u201332. 10.1038\/jcbfm.2010.202","journal-title":"J Cereb Blood Flow Metab"},{"key":"425_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2007.09.043","volume":"428","author":"J Jolkkonen","year":"2007","unstructured":"Jolkkonen J, Jokivarsi K, Laitinen T, Gr\u00f6hn O: Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions.\n                           Neurosci Lett. 2007, 428:99\u2013102. 10.1016\/j.neulet.2007.09.043","journal-title":"Neurosci Lett"},{"key":"425_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12015-013-9492-x","volume":"10","author":"J Ge","year":"2014","unstructured":"Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RC, et al.: The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke.\n                           Stem Cell Rev. 2014, 10:295\u2013303. 10.1007\/s12015-013-9492-x","journal-title":"Stem Cell Rev"},{"key":"425_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1089\/scd.2013.0338","volume":"23","author":"L Guo","year":"2014","unstructured":"Guo L, Ge J, Zhou Y, Wang S, Zhao RC, Wu Y: Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection.\n                           Stem Cells Dev. 2014, 23:978\u201389. 10.1089\/scd.2013.0338","journal-title":"Stem Cells Dev"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jcyt.2014.05.004","volume":"16","author":"DH Hickerson","year":"2014","unstructured":"Hickerson DH, White HS, Nguyen A, Nieman E, Meadows N, Gentry T, et al.: Development of a flow cytometry-based pulse-width assay for detection of aggregates in cellular therapeutics to be infused by catheter.\n                           Cytotherapy. 2014, 16:1545\u201357. 10.1016\/j.jcyt.2014.05.004","journal-title":"Cytotherapy"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbr.2012.06.014","volume":"234","author":"CL Nemeth","year":"2012","unstructured":"Nemeth CL, Shurte MS, McTigue DM, Nemeroff CB, Neigh GN: Microembolism infarcts lead to delayed changes in affective-like behaviors followed by spatial memory impairment.\n                           Behav Brain Res. 2012, 234:259\u201366. 10.1016\/j.bbr.2012.06.014","journal-title":"Behav Brain Res"},{"key":"425_CR27","volume-title":"Cell Transplant","author":"J Khabbal","year":"2014","unstructured":"Khabbal J, Kerkela E, Mitkari B, Raki M, Nystedt J, Mikkonen V: Differential clearance of rat and human bone marrow-derived mesenchymal stem cells from the brain after intra-arterial infusion in rats.\n                           Cell Transplant 2014. DOI: 10.3727\/096368914X679336"},{"key":"425_CR28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10856-014-5157-9","volume":"25","author":"W Jiang","year":"2014","unstructured":"Jiang W, Liang G, Li X, Li Z, Gao X, Feng S, et al.: Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAO.\n                           J Mater Sci Mater Med. 2014, 25:1357\u201366. 10.1007\/s10856-014-5157-9","journal-title":"J Mater Sci Mater Med"},{"key":"425_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2012.09.018","volume":"239","author":"B Mitkari","year":"2013","unstructured":"Mitkari B, Kerkela E, Nystedt J, Korhonen M, Mikkonen V, Huhtala T, et al.: Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats.\n                           Exp Neurol. 2013, 239:158\u201362.","journal-title":"Exp Neurol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/scrt544\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:26:35Z","timestamp":1728908795000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/scrt544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/scrt544","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]},"assertion":[{"value":"17 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}